A U.S. study found that cord blood cells are a suitable alternative to bone marrow or peripheral blood progenitor cells for acute leukemia patients who need a stem cell transplant. The research showed that cord blood transplants have longer engraftment time and greater mortality but less later morbidity compared with other stem cell sources.

Related Summaries